Search results
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 1 day agoImportantly, none of the participants experienced Guillain-Barré syndrome (GBS), a rare neurological...
GSK plc (NYSE:GSK) Stock Position Decreased by Peapack Gladstone Financial Corp
ETF DAILY NEWS· 18 hours agoPeapack Gladstone Financial Corp cut its stake in shares of GSK plc (NYSE:GSK – Free Report) by 5.9% in the 4th quarter, according to the company in its ...
US FDA approves Moderna’s RSV vaccine, its second marketed product
WHTC 1450 Holland· 6 days agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 7 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 14 hours agoA long-term analysis, extending over 8.6 months median follow-up, found that the vaccine displayed...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 6 days agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year —...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 6 days agoModerna announced on Friday that the U.S. Food and Drug Administration (FDA) has approved its...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 7 days agoThe FDA recently delayed its decision on the Moderna vaccine to the end of the month. If approved,...
Glaxo (GSK) Up 1.6% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 6 days ago/Seretide sales were down 13%, while sales of Revlar/Breo Ellipta were up 4%. In General Medicines, ...